CRESCENT CAPITAL BDC CCAP 深 沪
交易中 10-30 12:13:46 美东时间
14.18
-0.210
-1.46%
华盛通- 最 高14.47
- 今 开14.39
- 成交量 4.02万股
- 最 低 14.10
- 昨 收 14.39
- 总市值 5.26亿
- 52周最高 18.78
- 市盈率 静 7.14
- 换手率 0.11%
- 52周最低 12.60
- 委 比 -23.08%
- 总股本 3706.15万
- 历史最高 18.78
- 量 比 0.54
- 振 幅 2.57%
- 历史最低 -4.17
- 每 手 1
- 风险率 1.58%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多喜报 | 谱尼测试获一汽解放汽车实验室认可
近日，谱尼测试（股票代码：300887）正式通过一汽解放汽车的严格审核与能力验证，成功获得其认可。这一成果充分体现了一汽解放汽车对谱尼测试集团在汽车检测领域技术...
09-22 08:06
Clear Street Initiates Coverage On Crescent Capital BDC with Buy Rating, Announces Price Target of $16.5
Clear Street analyst Mickey Schleien initiates coverage on Crescent Capital BDC (NASDAQ:CCAP) with a Buy rating and announces Price Target of $16.5.
09-05 18:02
Crescent Capital BDC NII of $0.46
Crescent Capital BDC press release (NASDAQ:CCAP): Q2 net investment income per share of $0.46. Total investment income of $42.99M. More on Crescent Capital BDC Crescent Capital BDC: Unfairly Discounte...
08-14 04:24
Earnings Scheduled For August 13, 2025
Companies Reporting Before The Bell • Evotec (NASDAQ:EVO) is projected to repor...
08-13 16:32
Crescent Capital BDC Q2 2025 Earnings Preview
Crescent Capital BDC (NASDAQ:CCAP) is scheduled to announce Q2 earnings results on Wednesday, August 13th, after market close. The consensus EPS Estimate is $0.47 and the consensus Revenue Estimate is...
08-13 05:35
Crescent Capital BDC, Inc. Schedules Earnings Release and Conference Call to Discuss its Second Quarter Ended June 30, 2025 Financial Results
Crescent BDC (NASDAQ: CCAP) announced it will release its second quarter 2025 financial results on August 13, 2025 after market close. A webcast/conference call to discuss the results is scheduled for August 14, 2025 at 12:00 p.m. ET, accessible via its website or by dialing (800) 715-9871 with conference ID 1217499. A replay will be available on its site. The company provides capital solutions to middle market firms and is externally managed by ...
07-29 20:05
美股大行评级 | 潜在涨幅2840.31%！Mersana Therapeutics获Truist Securities升目标价至10美元，维持"买入"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1130419824951111681.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Truist Securities：维持Mersana Therapeutics(MRSN)"买入"评级，目标价从9美元升至10美元</p> <p>• Guggenheim：维持Cabaletta Bio(CABA)"买入
05-17 08:44
Crescent Capital BDC Navigates Earnings Amid Challenges
Crescent Capital Bdc, Inc. (($CCAP)) has held its Q1 earnings call. Read on for...
05-16 08:25
Crescent Capital BDC Q1 Net investment income per share $0.45 Misses $0.52 Estimate, Total investment income $42.13M Miss $45.08M Estimate
Crescent Capital BDC (NASDAQ:CCAP) reported quarterly earnings of $0.45 per share which missed the analyst consensus estimate of $0.52 by 13.46 percent. This is a 28.57 percent decrease over earnings of $0.63 per share
05-15 04:12
Earnings Scheduled For May 14, 2025
Companies Reporting Before The Bell • Cellebrite DI (NASDAQ:CLBT) is expected t...
05-14 16:32
